Legal Status and Future Outlook As of May 2026, Retatrutide remains investigational and is not yet FDA-approved for retail pharmaceutical distribution or general consumer use
503A patient-specific compounding might continue under narrow, individually justified circumstances - but not at the volume or pricing that made telehealth-based compounded GLP-1 programs commercially viable
Periodic check-ins are completed online, and the care team can adjust dosage or modify the treatment plan based on those interactions without requiring a separate appointment
They may recommend an alternative, including perhaps a prescription medication, that would be better suited for you
One person may tolerate a medication well
Even if you know some of the main points to consider before purchasing a glutathione supplement, you might still have some unanswered questions on your mind